{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:12:21Z","timestamp":1762459941750,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.023","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T01:42:20Z","timestamp":1609378940000},"page":"853-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 &amp; 18): Regulatory toxicology studies in mice, rats and rabbits \u2013 An innovative approach"],"prefix":"10.1016","volume":"39","author":[{"given":"Y.","family":"Srinivasa Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Narendra Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Uday Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Harishankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.Y.H.","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Surekha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hemalatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dinesh Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.023_b0005","first-page":"1543","article-title":"Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer","volume":"18","author":"Ahmed","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.vaccine.2020.11.023_b0010","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.2147\/OTT.S251926","article-title":"Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers","volume":"13","author":"Chintala","year":"2020","journal-title":"OncoTargets Therapy"},{"key":"10.1016\/j.vaccine.2020.11.023_b0015","first-page":"341","article-title":"Human papillomavirus vaccines: current issues & future","volume":"130","author":"Kawana","year":"2009","journal-title":"Indian J Med Res"},{"unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in India. Summary Report 17 June 2019","key":"10.1016\/j.vaccine.2020.11.023_b0020"},{"key":"10.1016\/j.vaccine.2020.11.023_b0025","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent Vaccine against Human Papilloma virus to Prevent High-Grade Cervical Lesions","volume":"356","author":"Koutsky","year":"2007","journal-title":"N Engl J Med"},{"unstructured":"Centers for Disease Control and Prevention (CDC). Syncope after vaccination - United States, January 2005-July 2007. Morb Mortal Wkly Rep. 2008; 2;57(17):457-60.","key":"10.1016\/j.vaccine.2020.11.023_b0030"},{"key":"10.1016\/j.vaccine.2020.11.023_b0035","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1016\/j.vaccine.2018.08.071","article-title":"Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity","volume":"36","author":"Wise","year":"2018","journal-title":"Vaccine"},{"unstructured":"Program for Appropriate Technology in Health (PATH). 2006. Current and Future HPV Vaccines: Promise and Challenges . Seattle, USA.","key":"10.1016\/j.vaccine.2020.11.023_b0040"},{"key":"10.1016\/j.vaccine.2020.11.023_b0045","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1128\/JVI.72.10.8220-8229.1998","article-title":"Nasal immunization of mice with human papilloma virus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions","volume":"72","author":"Balmelli","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.11.023_b0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC)","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2020.11.023_b0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.23252","article-title":"Recent advances in strategies for immunotherapy of human papilloma virus-induced lesions","volume":"122","author":"Kanodia","year":"2008","journal-title":"Int. J Cancer"},{"key":"10.1016\/j.vaccine.2020.11.023_b0060","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.11.023_b0065","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1128\/JVI.01583-06","article-title":"Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV\/cottontail rabbit papillomavirus chimeric papillomavirus particles","volume":"80","author":"Mejia","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.023_b0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","article-title":"Reactivity of human sera in a sensitive, high-throughput pseudo virus-based papilloma virus neutralization assay for HPV16 and HPV18","volume":"321","author":"Pastrana","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.11.023_b0075","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/iai.65.8.3328-3336.1997","article-title":"Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice","volume":"65","author":"Nardelli-Haefliger","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.023_b0080","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/CVI.00164-07","article-title":"Salmonella enterica Serovar Typhi Ty21a Expressing Human Papilloma virus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever","author":"Fraillery","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.023_b0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.68.1.205-213.2000","article-title":"In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors","volume":"68","author":"Pickett","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.023_b0090","first-page":"373","article-title":"Construction of a vector for the constitutive expression of Human Papillomavirus type 16 genes in Salmonella enterica serovar Typhi strain Ty21a","volume":"6","author":"Ponnanna","year":"2012","journal-title":"Curr Trends Biotechnol Pharm"},{"unstructured":"Paget GE and Barnase JM. (1964) Evaluation of Drug Activities: Pharmaocometrics Ed. Laurence.D.R & Bocharach.A.L.., Vol.1. Academic Press, New York","key":"10.1016\/j.vaccine.2020.11.023_b0095"},{"unstructured":"WHO guidelines on nonclinical evaluation of vaccines; 2005. Available at <http:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/nonclinical_evaluation\/ANNEX%201Nonclinical.P31-63.pdf>.","key":"10.1016\/j.vaccine.2020.11.023_b0100"},{"key":"10.1016\/j.vaccine.2020.11.023_b0105","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.vaccine.2006.01.002","article-title":"Nonclinical toxicology study of recombinant-plasmid DNA anti-rabies vaccines","volume":"24","author":"Kumar","year":"2006","journal-title":"Vaccine"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2020.11.023_b0110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0264-410X(96)00227-7","article-title":"A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens","volume":"15","author":"Galen","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.023_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymeth.2005.09.012","article-title":"Rational design of Salmonella-based vaccination strategies","volume":"38","author":"Spreng","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2020.11.023_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.reprotox.2010.09.001","article-title":"Evaluation of the intramuscular administration of CervarixTM vaccine on fertility, pre- and postnatal development in rats","volume":"31","author":"Segal","year":"2011","journal-title":"Reprod Toxicol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:21Z","timestamp":1759402281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20314638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20314638"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits \u2013 An innovative approach","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}